<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03496285</url>
  </required_header>
  <id_info>
    <org_study_id>ACCUMBENS</org_study_id>
    <nct_id>NCT03496285</nct_id>
  </id_info>
  <brief_title>Accumbofrontal Tract Study in 2 Populations of Patients With Anorexia Nervosa and Obsessional Compulsive Disorder and Healthy Volunteer</brief_title>
  <acronym>ACCUMBENS</acronym>
  <official_title>Multimodal MRI Study of Accumbofrontal Tract in Anorexia Nervosa and Obessional Compulsive Disorder : Search for Structural and Functional Changes Between Orbito-frontal Cortex and Accumbens Nucleus Subdivisions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Restrictive anorexia nervosa and TOCs are psychiatric diseases which shares a common&#xD;
      pathophysiological substrate We hypothesize that anorexia patients and patients with OCD have&#xD;
      structural and functional changes in the accumbofrontal tract. The main objective of this&#xD;
      study will be to compare the structure and the connectivity of this tract in MRI with&#xD;
      diffusion sequences (DTI tractography) and resting-state, in 3 distinct populations of&#xD;
      anorexic patients, patients with OCD and healthy patients. The role of the accumbo-frontal&#xD;
      tract in the cortico-striato-hypothalamo-cortical circuit seems to be established. DTI&#xD;
      tractography will allow the measurement of functional anisotropy (FA), a parameter that&#xD;
      evaluates the diffusion of water molecules along the white matter fibers, and therefore the&#xD;
      potential alteration of the studied tract. Resting state sequences will allow to estimate the&#xD;
      BOLD signal and the functionality of the tract.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 9, 2018</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional Anisotropy (probabilistic tractography)</measure>
    <time_frame>20 minutes</time_frame>
    <description>Evaluate the mean functional anisotropy value for fiber bundles connecting the orbito-frontal cortex and the nucleus accumbens</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BOLD Signal (resting state)</measure>
    <time_frame>20 minutes</time_frame>
    <description>Evaluate the value of the BOLD-signal of the fiber bundles connecting the orbito-frontal cortex and the nucleus accumbens</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Accumbo Frontal Tract</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Multimodal MRI with diffusion sequence for anorexia nervosa patient</intervention_name>
    <description>Multimodal MRI with diffusion sequence, resting state, T2, T1 without gadolinium contrast</description>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Multimodal MRI with diffusion sequence for obsessional compulsive disorder patient</intervention_name>
    <description>Multimodal MRI with diffusion sequence, resting state, T2, T1 without gadolinium contrast</description>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Multimodal MRI with diffusion sequence for healthy volunteer</intervention_name>
    <description>Multimodal MRI with diffusion sequence, resting state, T2, T1 without gadolinium contrast</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female patients&#xD;
&#xD;
          -  Age between 18 and 65 years&#xD;
&#xD;
          -  Subjects free to give their written consent&#xD;
&#xD;
        For anorexia nervosa :&#xD;
&#xD;
          -  Patients meeting the diagnostic criteria for anorexia nervosa according to DSM5&#xD;
             (American Psychiatric Association): low weight (&lt;85% of expected weight for age and&#xD;
             height), fear of gaining weight or becoming fat, distortion of body image, and&#xD;
             amenorrhea for more than 3 months&#xD;
&#xD;
          -  Treatment with at least one antidepressant and one anxiolytic&#xD;
&#xD;
        For OCD :&#xD;
&#xD;
          -  Patients meeting the diagnostic criteria of OCDs according to DSM5 (American&#xD;
             Psychiatric Association) : presence of obsessions and / or compulsions, resulting in&#xD;
             clinically significant suffering (loss of at least one hour per day) or impairment at&#xD;
             the social, occupational level or in another important area of life. These symptoms&#xD;
             are not due to the physiological effects of a substance or a general medical condition&#xD;
             and cannot be better explained by the symptoms of another psychiatric disorder.&#xD;
&#xD;
          -  Patients with homogeneous OCD in obsession and compulsion.&#xD;
&#xD;
          -  Normal weight compared to expected weight for age and height&#xD;
&#xD;
          -  Treatment with at least one antidepressant and one anxiolytic&#xD;
&#xD;
        ForHealthy volunteer&#xD;
&#xD;
        •Normal weight compared to expected weight for age and height&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Age &lt;18 years or&gt; 65 years&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Absence of free and informed consent signature&#xD;
&#xD;
          -  Current processing by rTMS&#xD;
&#xD;
          -  Somatic intercurrent pathologies: neurological, cardiological, pneumological, renal,&#xD;
             hepatic, endocrine, metabolic disorders ...&#xD;
&#xD;
          -  Mental retardation (WAIS-IV QI &lt;70)&#xD;
&#xD;
          -  Primary Amenorrhea&#xD;
&#xD;
          -  Absolute contraindication or relative to the realization of a magnetic resonance&#xD;
             imaging without injection of contrast medium&#xD;
&#xD;
          -  Old or intercurrent psychotic pathology&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Benoît BATAILLE</last_name>
    <phone>05 49 44 45 85</phone>
    <email>benoit.bataille@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christophe BOULLOUD</last_name>
    <phone>05 49 44 45 85</phone>
    <email>christophe.boulloud@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Laborit</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HARIKA GERMANEAU</last_name>
      <phone>0549445802</phone>
      <email>ghina.harika-germaneau@ch-poitiers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 5, 2018</study_first_submitted>
  <study_first_submitted_qc>April 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

